(September 20, 2010) — Integra Technologies LLC, IC test and evaluation services provider, was selected by Proteus Biomedical Inc. for development and production test of their new integrated circuit (IC) designs.
Proteus’ products address therapeutic areas where disease management complexity, patient monitoring requirements, therapeutic efficacy, and poor patient adherence create large clinical and commercial opportunities. The company currently has two product platforms in development for application in immunology, diabetes, tuberculosis, HIV, cardiac disease and CNS disorders. Visit the medical and life sciences center on ElectroIQ.com here.
Commenting on the new partnership, Ben Costello, VP of product engineering of Proteus Biomedical, cited Integra’s experience, engineering expertise, certifications, quality record and manufacturing capability as reasons for the contract.
"Proteus has exciting products coming to market and we look forward to utilizing our substantial engineering and manufacturing expertise and capacity to support their successful introduction and volume ramp," added Joe Holt, president of business development for Integra. Watch a video interview with Andrew Thompson, Proteus Biomedical, about medical electronics here.
Proteus Biomedical’s body-powered and implantable technologies are the foundation for the development of the company’s intelligent medical products. More information about Proteus Biomedical can be found at www.proteusbiomed.com
Integra Technologies is an independent test lab in the U.S and Europe and is a full service test supplier. Services include: Test Development, Final Test, Characterization, Wafer Probe, ESD, Latch-Up, Qualification services (HTOL, HAST, Temp Cycle, etc.) and assembly (outsourced to qualified partners). Additional information about Integra Technologies can be found at www.Integra-Tech.com.